Related Experiment Video
Updated: Jul 26, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Long-term follow-up of valvotomy before 1968 for congenital aortic stenosis
Insights
Valvotomy for aortic stenosis offered palliative relief, with long-term survival rates improving significantly over 22 years. However, reoperation and bacterial endocarditis remain serious risks, necessitating vigilant patient monitoring.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Medicine
Background:
- Aortic stenosis is a significant valvular heart disease.
- Valvotomy was an early surgical intervention for aortic stenosis.
- Long-term outcomes of early valvotomy are not well-established.
Purpose of the Study:
- To review the long-term clinical course of patients who underwent valvotomy for aortic stenosis.
- To assess survival rates, reoperation rates, and incidence of bacterial endocarditis.
- To emphasize the need for meticulous follow-up in patients treated with valvotomy.
Main Methods:
- Retrospective review of 59 patients who underwent valvotomy for aortic stenosis before 1968.
- Actuarial analysis of survival, reoperation, and serious adverse events (death, reoperation, endocarditis).
- Analysis of clinical data including symptoms, electrocardiograms, and cardiac catheterization findings.
Main Results:
- Actuarial survival was 94% at 5 years and 77% at 22 years.
- Reoperation was required in 36% of patients, with a 44% probability by 22 years.
- Serious adverse events occurred in 61% of patients by 22 years, with bacterial endocarditis in 3.8 episodes/1,000 patient-years.
Conclusions:
- Valvotomy for aortic stenosis provides palliative relief but is not curative.
- Long-term survival is achievable, but reoperation and complications like endocarditis are common.
- Meticulous and lifelong follow-up is crucial for managing patients after valvotomy.
Abstract:
The clinical course of 59 patients who underwent valvotomy for aortic stenosis before 1968 was reviewed. All were older than 1 year at the time of operation. Mean follow-up period was 17.7 years. Forty-six patients are alive; 26 (57%) are 30 to 40 years and 6 (13%) are older. Actuarial analysis indicated that the probability of survival was 94% at 5 years and 77% at 22 years. Thirteen patients died, 7 suddenly. Among the latter, significant obstruction or regurgitation was present in the 4 who underwent catheterization 0.9 to 7.2 years before death, 2 of whom were symptomatic and 2 with progression of a strain pattern on electrocardiogram. Surgery was recommended but declined by the latter 2 patients. Reoperation was carried out in 21 patients (36%), 3 (12%) of whom died. Actuarial analysis revealed the probability of reoperation to increase from 2% at 5 years to 44% at 22 years. Bacterial endocarditis occurred on 4 occasions in 3 patients, 1 of whom died suddenly during treatment. The incidence of endocarditis was 3.8 episodes/1,000 patient-years. Actuarial analysis of serious events, defined as death, reoperation and endocarditis, with the most serious of these and each patient being represented only once, indicated the probability of being free of such an episode to be 92% at 5 years, decreasing to 39% at 22 years. These data emphasize the palliative nature of valvotomy and the meticulous follow-up so necessary in these patients.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation III: Medical Management

